The online versions of legislation provided on this website are not official. Enrolled bills are the final version passed by the Ohio General Assembly and presented to the Governor for signature. The official version of acts signed by the Governor are available from the Secretary of State's Office in the Continental Plaza, 180 East Broad St., Columbus.
S. B. No. 271 As IntroducedAs Introduced
|130th General Assembly|
To enact section 4729.553 of the Revised Code to
require a retail terminal distributor of dangerous
drugs to verify the prospective purchaser's
identity when dispensing a controlled substance or
BE IT ENACTED BY THE GENERAL ASSEMBLY OF THE STATE OF OHIO:
Section 1. That section 4729.553 of the Revised Code be
enacted to read as follows:
Sec. 4729.553. (A) As used in this section, "purchaser" means
an individual engaged in the act of purchasing a dangerous drug
from a licensed terminal distributor of dangerous drugs and
includes either the individual for whom the prescription for the
drug is issued or an individual acting on behalf of the individual
for whom the prescription is issued.
(B) Except as provided in division (E) of this section, prior
to selling at retail a controlled substance or drug containing
tramadol, a licensed terminal distributor of dangerous drugs shall
do both of the following:
(1) Verify the identity of the prospective purchaser of the
drug against either of the following:
(a) A valid identification card bearing a photograph of the
prospective purchaser, issued by a state or federal agency;
(b) A form of identification authorized by the state board of
pharmacy in rules adopted under division (D) of this section.
(2) Record all of the following:
(a) The name of the individual purchasing the drug;
(b) The type of identification presented;
(c) The unique identification number printed by the issuing
agency on the identification, if the number exists.
(C) The terminal distributor shall retain the information
required by division (B) of this section for three years. The
information is subject to inspection for official purposes by law
enforcement officers and employees of the board.
(D) The board may adopt rules authorizing for purposes of
this section the use of identification other than that described
in division (B)(1)(a) of this section. The rules shall be adopted
in accordance with Chapter 119. of the Revised Code.
(E) Division (B) of this section does not apply when a drug
is being purchased for use in administering the drug to an
individual who is receiving care in or through a hospital,
ambulatory surgical facility, nursing home, residential care
facility, freestanding rehabilitation facility, hospice care
program, home and community-based services provider, residential
facility for individuals with mental illness or developmental
disabilities, physician office, or any similar health care
facility, location, or provider.